Table 3.
Proportion of patients with any mental disorder |
Univariate regression model |
Multivariate regression modela |
||||
---|---|---|---|---|---|---|
% | n | OR 95% CI | P | OR 95% CI | P | |
Age | 0.42 (0.31-0.57) | <0.001 | 0.42 (0.30-0.59) | <0.001 | ||
<60b | 29.0 | 130 | ||||
≥60 | 14.6 | 85 | ||||
Sex | 1.81 (1.34-2.47) | <0.001 | 1.22 (0.79-1.87) | 0.37 | ||
Menb | 16.1 | 85 | ||||
Women | 25.8 | 130 | ||||
SES | ||||||
Lowb | 23.8 | 49 | ||||
Medium | 21.2 | 131 | 0.86 (0.59-1.26) | 0.43 | ||
High | 16.8 | 35 | 0.65 (0.40-1.05) | 0.08 | ||
Residential area | 1.22 (0.90-1.66) | 0.20 | ||||
Rural <20 000 inhabitantsb | 19.0 | 86 | ||||
Urban ≥20 000 inhabitants | 22.2 | 127 | ||||
Partner | 1.97 (1.40-2.75) | <0.001 | 1.84 (1.28-2.62) | <0.001 | ||
Yesb | 18.4 | 144 | ||||
No | 30.8 | 69 | ||||
Tumor entity | ||||||
Breastc | 21.1 | 27 | ||||
Melanoma | 14.2 | 29 | 0.62 (0.35-1.11) | 0.11 | 0.74 (0.40-1.39) | 0.35 |
Prostate | 9.5 | 14 | 0.39 (0.19-0.77) | 0.008 | 0.77 (0.32-1.75) | 0.53 |
Digestive organs | 23.2 | 36 | 1.13 (0.65-2.00) | 0.67 | 1.64 (0.86-3.11) | 0.13 |
Female genital organs | 39.3 | 56 | 2.42 (1.42-4.19) | 0.001 | 2.45 (1.41-4.34) | 0.002 |
Kidney/urinary tract | 20.2 | 16 | 0.95 (0.46-1.88) | 0.61 | 1.49 (0.67-3.23) | 0.32 |
Head and neck | 18.1 | 11 | 0.83 (0.37-1.77) | 0.88 | 1.06 (0.44-2.41) | 0.89 |
Lung | 15.0 | 6 | 0.66 (0.22-1.67) | 0.41 | 1.05 (0.33-2.85) | 0.93 |
Other | 26.7 | 20 | 1.36 | 0.36 | 1.70 | 0.17 |
UICC | ||||||
Ib | 21.9 | 97 | ||||
II | 20.3 | 43 | 0.91 (0.60-1.36) | 0.65 | ||
III | 20.7 | 36 | 0.93 (0.60-1.42) | 0.75 | ||
IV | 22.1 | 30 | 1.01 (0.63-1.59) | 0.97 | ||
Level of morbidity or impairmentd | 1.03 (1.01-1.05) | <0.001 | 1.05 (1.03-1.07) | <0.001 |
Logistic regression model on any mental disorder, weighted by SES; significant values marked in bold.
CI, confidence interval; OR, odds ratio; SES, socioeconomic status; UICC, Union for International Cancer Control.
All relevant factors from univariate regression model (P < 0.05).
Reference group.
Breast cancer was chosen as reference group, since its prevalence rate for any mental disorder was close to the overall prevalence rate.
Level of morbidity or impairment by chronic physical comorbidities in daily life, adapted version by Bayliss et al. 2005, higher values indicate higher morbidity or impairment.